TYLENOL ARTHRITIS PAIN EXTENDED RELIEF 650mg Price

Overview

Welcome to Dwaey, specifically on TYLENOL ARTHRITIS PAIN EXTENDED RELIEF 650mg Tablets (Caplets)/Extended Release page.
This medicine contains an important and useful components, as it consists of Paracetamol.
TYLENOL ARTHRITIS PAIN EXTENDED RELIEF 650mg is available in the market in concentration 650mg/Tablet and in the form of Tablets (Caplets)/Extended Release.

MCNEIL CONSUMER & SPECIALTY PHARMACEUTICALS is the producer of TYLENOL ARTHRITIS PAIN EXTENDED RELIEF 650mg and it is imported from USA, The most popular alternatives of TYLENOL ARTHRITIS PAIN EXTENDED RELIEF 650mg are listed downward .

Mode Of Action

Paracetamol exhibits analgesic action by peripheral blockage of pain impulse generation. It produces antipyresis by inhibiting the hypothalamic heat-regulating centre. Its weak anti-inflammatory activity is related to inhibition of prostaglandin synthesis in the CNS.

Indication

• Fever ans Mild to moderate pain such as osteoarthritis
• rheumatoid arthritis
• chronic low back pain
• Renal stone pain
• neuropathic pain
• toothache
• migraine
• postoperative mild to moderate pain.

Precaution

Patient w/ chronic alcoholism, known G6PD deficiency, severe hypovolaemia, chronic malnutrition. Renal and hepatic impairment. Pregnancy and lactation. Monitoring Parameters Monitor serum paracetamol levels esp when acute overdosage is suspected and w/ long-term use.

Side Effects

• Thrombocytopenia
• leucopenia
• pancytopenia
• neutropenia
• agranulocytosis
• pain and burning sensation at inj site. Rarely
• hypotension and tachycardia. Potentially Fatal: Stevens-Johnson syndrome
• toxic epidermal necrolysis
• acute generalised exanthematous pustulosis
• acute renal tubular necrosis and hepatotoxicity.

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.